Nr.
Eintrag
1
Gümüsay, Ali Aslan :Die Position: Wissenschaftler, mischt euch endlich ein! : Es reicht nicht mehr aus, nur Fakten zu analysieren. Sonst gewinnen die Populisten
2
Jasanoff, Sheila :Science and public reason
3
Macaluso, Matthew ; Krams, Michael ; Preskorn, Sheldon H :Phase I trials: from traditional to newer approaches. Part I.
4
Carbone, Julia et al.: DNA patents and diagnostics: not a pretty picture.
5
Furman, Jeffrey L ; Murray, Fiona ; Stern, Scott :More for the research dollar.
6
Gottesman, Michael M ; Jaffe, Holli Beckerman :Commentary: A delicate balance: weighing the effects of conflict-of-interest rules on intramural research at the National Institutes of Health.
7
Loise, Vicki ; Stevens, Ashley J :The Bayh-Dole Act turns 30.
8
Williams, Russell ; Morin, Yves :CIHR and Prigent.
9
Zinner, Darren E et al.: Tightening conflict-of-interest policies: the impact of 2005 ethics rules at the NIH.
10
Herzfeld, Noreen L. :The new alchemy
11
Schofield, Paul N. et al.: Post-publication sharing of data and tools
12
Schulman, Kevin A. ; Vidal, Ana Valverde ; Ackerly, D. Clay :Personalized medicine and disruptive innovation: implications for technology assessment
13
Selinger, Evan :Technology transfer
14
Amechi, Emeka Polycarp :Regulating developments in embryonic stem cell research in Africa: a third person's perspective.
15
Boon, Wouter ; Moors, Ellen :Exploring emerging technologies using metaphors--a study of orphan drugs and pharmacogenomics.
16
Greco, Dirceu ; Diniz, Nilza Maria :Conflicts of interest in research involving human beings
17
Ledbetter, David H. :Gene patenting and licensing: the role of academic researchers and advocacy groups
18
Matthijs, Gert ; Hodgson, Shirley :The impact of patenting on DNA diagnostic practice.
19
Peng, Zhaohui ; Yu, Qing ; Bao, Li :The application of gene therapy in China.
20
Andanda, A.P. :Health-related biotechnology in Africa: managing the legislative and regulatory issues.
